NCT03722602

Brief Summary

The study enabled assessment of changes in body mass composition, metabolic syndrome and lipid profile in patients after stroke, following rehabilitation in hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 22, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

October 29, 2018

Completed
Last Updated

October 30, 2018

Status Verified

October 1, 2018

Enrollment Period

1.8 years

First QC Date

May 22, 2018

Last Update Submit

October 26, 2018

Conditions

Keywords

strokeBMIbody compositionfunctional scales

Outcome Measures

Primary Outcomes (1)

  • Change Body composition assessment (fat mass, visceral fat level , muscle tissue, fat free mass , water content in the body) subjected to bioelectrical impedancy analysis - Tanita 780.

    Assessment of body composition (bioelectrical impedancy analysis - Tanita 780) Change from Baseline body composition at 5 weeks between baseline, after the end of protocol treatment, and 12 weeks after the end of the protocol treatment.

    at baseline, immediately after treatment completion, and 12 weeks after treatment completion

Secondary Outcomes (15)

  • Assessment of functional status was assessed using the Barthel Index. The subjects could score the maximum of 100 points.

    at baseline, immediately after treatment completion, and 12 weeks after treatment completion

  • Balance was assessed using Berg Balance Scale (BBS)

    at baseline, immediately after treatment completion, and 12 weeks after treatment completion

  • Assessment of muscle tone (spasticity) was examined with modified Ashworth scale.

    at baseline, immediately after treatment completion, and 12 weeks after treatment completion

  • Assessment of paretic limb function was assessed using the Brunnström scale.

    at baseline, immediately after treatment completion, and 12 weeks after treatment completion

  • Assessment of symmetry index for lower limb weight distribution

    at baseline, immediately after treatment completion, and 12 weeks after treatment completion

  • +10 more secondary outcomes

Study Arms (1)

Rehabilitation group

EXPERIMENTAL

Patients with stroke receiving standard inpatient rehabilitation for five weeks

Other: Standard rehabilitation after stroke

Interventions

The program of the rehabilitation was designed specifically for each patient. It was prepared to match the patient's functional status and the defined goals. The subjects participated in exercise five days per week, for five weeks. During their stay at the Clinic, the patients took part in morning exercise and received individual practice, based on neuro-developmental treatment (Bobath concept), and proprioceptive neuromuscular facilitation (PNF) method, addressing the impaired motor abilities; if it was needed they also performed exercise based on equipment using biological feedback: Balance Trainer (static and dynamic parapodium) and Pablo system designed for upper limb training.

Rehabilitation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke experienced.
  • Ability to stand without assistance.
  • Ability to walk without aid.
  • No impairments in higher mental functions
  • Patient's informed, voluntary consent to participate in the study.

You may not qualify if:

  • Lack of patient's consent to participate in the study
  • Lack of ability to stand without assistance.
  • Ischemic lesion located in the cerebellum and brain stem.
  • Metal, electronic implants.
  • Epilepsy.
  • Pregnancy.
  • Menstruation, in females.
  • Limb injuries incurred following stroke onset, prior to the exam.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rzeszów

Rzeszów, 35-205, Poland

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Justyna Leszczak, PhD

    University of Rzeszow

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 22, 2018

First Posted

October 29, 2018

Study Start

June 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

October 30, 2018

Record last verified: 2018-10

Locations